Chapter 301 On the Art of Cutting Leeks
July 18th.
Hong Kong.
As a key free port between East Asia and Southeast Asia today, the economy here has become somewhat active recently.
A large number of Chinese business families who fled from Siam, Malaysia and Singapore Island have settled down here, bringing in a lot of hot money.
On the other hand, it is because some of Zhiren Company's products often land in Hong Kong and then go north.
For example, the recently very popular Meisheng preventive medicine has attracted many people.
Li Qingye's 12 papers on how inflammation triggers damage to memory proteins, leading to Alzheimer's disease, have been reprinted in medical journals such as The Lancet, attracting great attention from researchers in related fields.
In fact, a large number of research teams in the international medical community have been doing work in this area. The current mainstream research direction of the international medical community on Alzheimer's disease is the inflammatory infection and amyloid protein deposition caused by intestinal flora.
However, the beta-amyloid protein in the amyloid protein has been exposed as a fraud in the paper since last year, and it was the fraud in the foundational paper.
This suddenly caused the medical community to doubt the entire amyloid protein deposition hypothesis.
Compared with the β-amyloid protein deposition that caused the collapse of the house, the research in the direction of inflammation has attracted great attention from major medical laboratories and pharmaceutical companies because of the new papers and new drugs by Li Qingye and the scientific research team of Zhiren Company.
Inside the medical laboratory of Hong Kong University.
A dozen Alzheimer's disease researchers from Hong Kong and the north are testing the clinical symptoms of the Meisheng preventive drug.
"From the brain dissection and test data of inflamed mice, it can be seen that inflammatory factors do affect the stability of alpha-25-2, alpha-25-6, and alpha-27-2 proteins." A middle-aged Mediterranean researcher holds up an experimental report.
Another middle-aged researcher with bloodshot eyes said in a very affirmative tone: "It seems that the research direction of Sapiens Company is correct."
"Don't be superstitious about authority. Science requires repeatability. I don't want to fall into another big pit again." The researcher who spoke was studying the deposition of beta-amyloid protein.
The Mediterranean researcher put down the experimental report in his hand and said, "In fact, it is not difficult to verify it. We can genetically modify mice so that the genes related to the synthesis of memory proteins are suppressed."
"The problem is that Sapiens has not published the gene sequences corresponding to these proteins. We can't test them one by one, right?" Another researcher wearing glasses spread his hands helplessly.
The researchers present were also very helpless about this.
Since the scientific research system within Sapiens is not connected to the international scientific community, even many of the public academic papers have their content truncated or the core data is deliberately blurred.
For example, in the 12 papers related to inflammatory factors causing Alzheimer's disease, there was no mention of gene sequences at all, nor was there any mention of which specific proteins the so-called A-series proteins were.
There is no trace of alpha-series proteins in the international medical and biological communities. Apparently, this is another term used internally by the Homo sapiens company.
Today, the research teams working on drugs and medicine are almost driven schizophrenia by Sapiens. Sometimes, when they get the "raw" version of Sapiens' papers, they find that they cannot understand them at all.
Even though the international academic community has written to Sapiens and Li Qingye many times, hoping that Sapiens could use some internationally accepted scientific terms instead of some unique terms.
However, their words had no effect on the Sapiens company.
No, it's even worse.
Sapiens not only likes to create scientific terms within the company, but also likes to use a mix of English, Chinese and Thai.
If the papers of Sapiens Company were of little value, the international academic community would regard these papers as a joke. However, the papers of Sapiens Company are related to many cutting-edge technologies, especially in the field of biopharmaceuticals.
For example, the current Alzheimer's disease paper, and the previous new antibiotics paper, artificial cornea paper and so on.
Don’t watch?
This is a scientific research paper in a cutting-edge field.
You said you just don’t want to watch it?
Don’t worry, the major pharmaceutical companies will let you watch it obediently.
Just like the medical laboratory of Hong Kong University right now, studying the efficacy of Meisheng's special medicine on Alzheimer's disease, it is the will of the capital behind it that is driving it.
Currently, all major pharmaceutical companies in the world, any pharmaceutical company with a little ambition, purchased the Meisheng preventive drug from Sapiens as soon as possible and then carried out animal experiments.
The Mediterranean researcher looked at the leader of another group of researchers and said, "Dr. Zhang, how is your component analysis going?"
Dr. Zhang, who looked tired, smiled bitterly: "The ingredients are already there, but there is no way to replicate them."
The Mediterranean researcher who knew something about the drugs of the Homo Sapiens company had already guessed: "Another brand new organic macromolecule?"
Dr. Zhang nodded. "Yes, it is a brand new protein structure. Its effect is very magical. After intravenous injection, this protein can penetrate the blood-brain barrier through blood circulation, enter the brain, and then break down into smaller subtypes of protein."
He continued: "These proteins interact with inflammatory factors, counteracting them while breaking down into various nutrients and a caffeine-like component that can greatly alleviate the adverse reactions caused by inflammation in the patient's brain."
"Is it possible to replicate subtypes of proteins?" the bespectacled researcher asked.
Dr. Zhang shook his head: "Even if this thing is copied, it can't get around the patent."
He was reminding those people in the team who were inserted by capital to give up when they saw difficulties.
After all, it is not easy to take things from the Sapiens company, and you might even lose your life.
As expected, when they heard about the patent issue, even the people from the pharmaceutical companies looked embarrassed. However, the huge profits behind the drugs made them unwilling to give in.
The pharmaceutical company representative asked, “Then can we study similar protein drugs?”
Dr. Zhang spread his hands and said, "This protein, which has such a precise effect and few side effects, is a very delicate structure. If it is a natural protein, it can be separated and refined. But I estimate that this protein is most likely artificially synthesized by Homo Sapiens Company."
"This means that it is difficult for us to find similar natural ingredients. We can only explore little by little, which requires a lot of research and development costs, and finally we may get a similar drug."
Of course, Dr. Zhang still has some things to say.
For example, the research cost may require tens of billions of US dollars and at least 5 to 10 years. Even if the drug is developed, the side effects of the first generation of drugs may be so severe that it cannot be marketed.
The pharmaceutical company representatives are not fools. If they cannot launch drugs with similar effects in a short period of time, they will not have to compete with Sapiens.
Even if we use trade barriers to block the entry of new drugs , there is no way to control smuggling, purchasing on behalf of others, medical tourism and the like.
What's more, the factory price of Meisheng preventive medicine is 5,000 gold yuan per box, and a special freezer must be used to ensure its shelf life of 3 years. If it is at room temperature, the Meisheng preventive medicine is only valid for about 30 days.
This thing is basically a product for the middle class and wealthy class.
According to the introduction of Sapiens, it is best to start taking the preventive medicine of Meisheng at the age of 20 to avoid the occurrence of Alzheimer's disease.
When cutting leeks, you should naturally cut the fattest ones.
Once other pharmaceutical companies develop similar drugs, Sapiens can cut prices and promote sales, making it unprofitable for other pharmaceutical companies.
Compared with before, pharmaceutical companies such as Pfizer and AstraZeneca are now firmly controlled by Sapiens' Langfu Anning.
After they developed the so-called miracle drug, they immediately lowered the price of Langfu Anning. In addition, the effect of Langfu Anning was immediate and its side effects were much less, which resulted in other pharmaceutical companies' drugs being unable to recover their research costs by selling at high prices.
This situation is extremely serious for many pharmaceutical companies.
Large pharmaceutical companies can still hold on, but small and medium-sized pharmaceutical companies may not be able to withstand even one wave, and their capital chain will be broken and they will go bankrupt.
